Dr. Kathleen Blake is a Denville, New Jersey based female chiropractor who is specialized as General Chiropractor. Active license number of Dr. Kathleen Blake as General Chiropractor is 38MC00463500 in New Jersey. Dr. Kathleen Blake is qualified as a Doctor of Chiropractic (D.C.), licensed by the State and who practices chiropractic medicine -that discipline within the healing arts which deals with the nervous system and its relationship to the spinal column and its interrelationship with other body systems.
Complete Profile:
Dr. Kathleen Blake speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Chiropractor
Credentials:
DC
Gender:
Female
Practice Address:
60 Broadway, Denville, New Jersey, 07834-2765
Phone:
862-209-4888
Fax:
862-209-4889
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1316050438
NPI Enumeration Date:
15 Aug, 2006
NPI Last Update On:
22 Feb, 2011
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Kathleen Blake are as mentioned below.
License Number
Specialization
State
Status
38MC00463500
Chiropractor
New Jersey
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
60 Broadway, Denville, New Jersey
Zip:
07834-2765
Phone Number:
862-209-4888
Fax Number:
862-209-4889
Patients can reach Dr. Kathleen Blake at 60 Broadway, Denville, New Jersey or can call to book an appointment on 862-209-4888. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.